IL1B and type 2 diabetes mellitus: In islets isolated from patients with type II diabetes and mice islets or INS1 cells treated with IL-1β and TNF-α, SIRT3 expression is markedly downregulated, which impairs β-cell function via abnormal elevation of ROS levels and amplification IL-1β synthesis (184).